Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70226 - 70250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	DISP1	84976	downregulated	Silicon Dioxide analog results in decreased expression of DISP1 mRNA	1q41	A24195
Silicon dioxide	Approved	DISP2	85455	upregulated	Silicon Dioxide analog results in increased expression of DISP2 mRNA	15q15.1	A24195
Silicon dioxide	Approved	DKC1	1736	upregulated	Silicon Dioxide analog results in increased expression of DKC1 mRNA	Xq28	A24195
Silicon dioxide	Approved	DKK1	22943	downregulated	Silicon Dioxide analog results in decreased expression of DKK1 mRNA	10q21.1	A24195
Silicon dioxide	Approved	DKK1	22943	upregulated	Silicon Dioxide results in increased expression of DKK1 mRNA	10q21.1	A24196 A24198
Silicon dioxide	Approved	DKK3	27122	downregulated	Silicon Dioxide analog results in decreased expression of DKK3 mRNA	11p15.3	A24195
Silicon dioxide	Approved	DKKL1	27120	downregulated	Silicon Dioxide analog results in decreased expression of DKKL1 mRNA	19q13.33	A24195
Silicon dioxide	Approved	DLC1	10395	upregulated	Silicon Dioxide results in increased expression of DLC1 mRNA	8p22	A24196
Silicon dioxide	Approved	DLEU1	10301	downregulated	Silicon Dioxide results in decreased expression of DLEU1 mRNA	13q14.2-q14.3	A24196
Silicon dioxide	Approved	DLG3	1741	downregulated	Silicon Dioxide analog results in decreased expression of DLG3 mRNA	Xq13.1	A24195
Silicon dioxide	Approved	DLGAP1	9229	upregulated	Silicon Dioxide analog results in increased expression of DLGAP1 mRNA	18p11.31	A24194
Silicon dioxide	Approved	DLGAP5	9787	downregulated	Silicon Dioxide analog results in decreased expression of DLGAP5 mRNA	14q22.3	A24195
Silicon dioxide	Approved	DLK1	8788	upregulated	Silicon Dioxide analog results in increased expression of DLK1 mRNA	14q32.2	A24195
Silicon dioxide	Approved	DLL3	10683	upregulated	Silicon Dioxide analog results in increased expression of DLL3 mRNA	19q13.2	A24195
Silicon dioxide	Approved	DLL4	54567	upregulated	Silicon Dioxide analog results in increased expression of DLL4 mRNA	15q15.1	A24194
Silicon dioxide	Approved	DLX1	1745	upregulated	Silicon Dioxide analog results in increased expression of DLX1 mRNA	2q31.1	A24195
Silicon dioxide	Approved	DLX2	1746	upregulated	Silicon Dioxide analog results in increased expression of DLX2 mRNA	2q31.1	A24194 A24195
Silicon dioxide	Approved	DLX2	1746	upregulated	Silicon Dioxide results in increased expression of DLX2 mRNA	2q31.1	A24197 A24196
Silicon dioxide	Approved	DLX4	1748	downregulated	Silicon Dioxide analog results in decreased expression of DLX4 mRNA	17q21.33	A24194 A24195
Silicon dioxide	Approved	DMBX1	127343	downregulated	Silicon Dioxide analog results in decreased expression of DMBX1 mRNA	1p33	A24195
Silicon dioxide	Approved	DMD	1756	downregulated	Silicon Dioxide analog results in decreased expression of DMD mRNA	Xp21.2-p21.1	A24195
Silicon dioxide	Approved	DMRT1	1761	upregulated	Silicon Dioxide analog results in increased expression of DMRT1 mRNA	9p24.3	A24195
Silicon dioxide	Approved	DMRTA1	63951	upregulated	Silicon Dioxide analog results in increased expression of DMRTA1 mRNA	9p21.3	A24194 A24195
Silicon dioxide	Approved	DMRTC1	63947	downregulated	Silicon Dioxide analog results in decreased expression of DMRTC1 mRNA	Xq13.1	A24195
Silicon dioxide	Approved	DMTN	2039	downregulated	Silicon Dioxide analog results in decreased expression of DMTN mRNA	8p21.3	A24195

Displaying entries 70226 - 70250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability